FDA Approves First Treatment Specifically for Giant Cell Arteritis (FREE)

By the Editors Subcutaneous tocilizumab (Actemra) is now approved for adults with giant cell arteritis, the FDA announced …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news
More News: Actemra